[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100638150":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":23,"locations":24,"responsibleParty":44,"collaborators":23,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":23,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":26,"whyStopped":23,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Maria Cecilia Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Digital technology","EXPERIMENTAL","Remote management of study participants, enabling the structured collection of relevant information for follow-up.",[13],"Other: Recommendations to the patient.",{"label":15,"type":6,"description":16,"interventionNames":17},"on site","adherence to in-person follow-up at the hospital.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"Recommendations to the patient.","Recommendations to the patient",[9,15],null,[25],{"facility":5,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Cotignola","Ravenna","48033","Italy","IT",{"type":33,"coordinates":34},"Point",[35,36],11.93852,44.38572,{"lat":36,"lon":35},[39],{"name":40,"role":41,"phone":42,"phoneExt":23,"email":43},"Anna Maria Malagoni, Dr","CONTACT","+390545217213","amalagoni@gvmnet.it",{"type":45,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100638150","cardiovascular-prevention-supported-by-digital-technology-comparison-with-the-traditional-model-100638150",false,"NCT07608926","Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model","DIGITAL PREV","Inclusion Criteria:\n\n* Age between 40 and 75 years\n* hypertension\n* hyperglycaemia\n* type 2 diabetes not requiring insulin therapy\n* dyslipidaemia\n* active smoking\n* overweight\u002Fgrade I obesity\n* Willingness to participate in follow-up visits over 24 months\n\nExclusion Criteria:\n\n* previous myocardial infarction\n* stroke\n* transient ischemic attack\n* coronary artery diseas\n* peripheral arterial occlusive disease\n* heart failure\n* Type 1 or type 2 diabetes mellitus on insulin therapy\n* Advanced chronic kidney disease (eGFR \\\u003C 30 mL\u002Fmin\u002F1.73 m²)\n* Active cancer disease\n* Severe obesity\n* Inability to use digital tools\n* Pregnancy","ALL","40 Years","75 Years",{"count":57,"type":58},144,"ESTIMATED","INTERVENTIONAL",[61],"NA","Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk.\n\nThis study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.",[64],"Cardiovascular (CV) Risk",[66,67],"Cardiovascular risk factors","Prevention","2026-05-19",{"date":70,"type":71},"2026-05-27","ACTUAL",{"date":73,"type":71},"2025-05-28",{"date":75,"type":58},"2028-06",{"name":5,"class":6},1]